Effects of glucocorticoids on the respiratory burst of Chlamydia-primed THP-1 cells.

Anti-Inflammatory Agents/pharmacology; Cell Differentiation; Cell Line; Chlamydophila pneumoniae/metabolism/pathogenicity/physiology; Electron Spin Resonance Spectroscopy; Ethylenes/biosynthesis; Gene Expression/drug effects; Humans; Hydrocortisone/pharmacology; Hydrogen Peroxide/metabolism; Interleukin-8/antagonists & inhibitors/biosynthesis; Membrane Transport Proteins/biosynthesis; Methylprednisolone/pharmacology; Monocytes/cytology/drug effects/metabolism/microbiology; NADPH Dehydrogenase/biosynthesis; NADPH Oxidase; NF-kappa B/metabolism; Phosphoproteins/biosynthesis; Reactive Oxygen Species/metabolism; Respiratory Burst/drug effects/physiology; Tumor Necrosis Factor-alpha/antagonists & inhibitors/metabolism

Abstract :

[en] We previously observed that the respiratory burst of human monocytes (THP-1 cell line) triggered by phorbol myristate acetate was strongly enhanced by a priming of the cells by Chlamydia pneumoniae [Biochem. Biophys. Res. Commun. 287 (2001) 781]. We describe here the modifications of the responses of Chlamydia-primed THP-1 cells to hydrocortisone (HCT) and methylprednisolone (MPL). HCT and MPL inhibited the production of the cytokines TNFalpha and IL-8. But HCT, which inhibited the respiratory burst in LPS-primed monocytes, paradoxically stimulated the phenomenon in Chlamydia-primed cells; MPL exerted no significant effect. Both glucocorticoids did not significantly modify the triggering effect of Chlamydia on NF-kappaB binding activity. On the expression of p22(phox), a protein subunit of the NADPH oxidase, HCT had an increasing and MPL a decreasing effect. Glucocorticoids thus had unexpected effects on the inflammatory response of Chlamydia-primed monocytes.

Disciplines :

Immunology & infectious disease

Author, co-author :

Mouithys-Mickalad, Ange ; Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)

Deby, Ginette ; Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)

Mathy, Marianne ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)

Habraken, Yvette ; Université de Liège - ULiège > GIGA-R : Virologie - Immunologie

Nys, Monique ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs - Anesthésie et réanimation

Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.) - Didactique des sciences de la santé - Pathologie générale et physiopathologie

Lamy, Maurice ; Centre Hospitalier Universitaire de Liège - CHU > Anesthésie et réanimation

Deby, Carol

Language :

English

Title :

Effects of glucocorticoids on the respiratory burst of Chlamydia-primed THP-1 cells.

Publication date :

2004

Journal title :

Biochemical and Biophysical Research Communications

ISSN :

0006-291X

eISSN :

1090-2104

Publisher :

Elsevier, Atlanta, United States - California

Volume :

318

Issue :

Pages :

941-8

Peer reviewed :

Peer reviewed

Available on ORBi :

since 06 April 2009

Statistics

Number of views

56 (0 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Ross R. Atherosclerosis-an inflammatory disease. Review. N. Engl. J. Med. 340:1999;115-126
Stary H.C., Chandler A.B., Glagov S., Guyton J.R., Insull W. Jr., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W., Wissler R.W. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis. Am. Heart Assoc. Circ. 89:1994;2462-2478
Libby P. Inflammation in atherosclerosis. Nature. 420:2000;868-874
Kaplan M., Aviram M. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase; Review. Clin. Chem. Lab. Med. 377:1999;77-87
Tangirala R.K., Mahlbergg F.H., Glick J.M., Jerome W.G., Rothblat G.H. Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. J. Biol. Chem. 268:1993;9653-9660
Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986
Kalayoglu M.V., Hoerneman B., LaVerda D., Morrison S.G., Morrison R.P., Byrne G.I. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J. Infect. Dis. 180:1999;780-790
Azumi H., Inoue N., Takeshita S., Rikitake Y., Kawashima S., Hayashi Y., Itoh H., Yokoyama M. Expression of NADH/NADPH oxidase p22 phox in human coronary arteries. Circulation. 100:1999;1494-1498
Miller F.J. Jr., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82:1998;1298-1305
Görlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87:2000;26-32
Mouithys-Mickalad A., Deby-Dupont G., Nys M., Lamy M., Deby C. Oxidative processes in human promonocytic cells (THP-1) after differentiation into macrophages by incubation with Chlamydia pneumoniae extracts. Biochem. Biophys. Res. Commun. 287:2001;781-788
Rydberg E.K., Salomonsson L., Hulten L.M., Noren K., Bondjers G., Wiklund O., Bjornheden T., Ohlsson B.G. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis. 170:2003;245-252
Green M.J., Hill A.O. Chemistry of dioxygen. Methods Enzymol. 105:1984;3-22
Eb V., Fuentes F., Orfila J. Method of titration of Chlamydia psittaci by immunofluorescence. J. Biol. Stand. 16:1988;219-224
Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M., Piette J. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IκBα in NF-κB activation by an oxidative stress. J. Immunol. 164:2000;4292-4300
Abrams J.T., Balin B.J., Vonderheid E.C. Association between Sezary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma. Ann. N. Y. Acad. Sci. 941:2001;69-85
Yamaguchi H., Haranaga S., Widen R., Friedman H., Yamamoto Y. Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect. Immun. 70:2002;2392-2398
Carratelli C.R., Rizzo A., Catania M.R., Galle F., Losi E., Hasty D.L., Rossano F. Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line. FEMS Microbiol. Lett. 215:2002;69-74
Kunkel S.L., Lukacs N.W., Chensue S.W., Strieter R.M. Chemokines and the inflammatory response. Remick D.G., Friedland J.S. Cytokines in Health and Disease. 1997;121-131 Marcel Dekker, New York
Takada Y., Mukhopadhyay A., Kundu G.C., Mahabeleshwar G.H., Singh S., Aggarwal B.B. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278:2003;24233-24241
Almawi W.Y., Melemedjian O.K. Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J. Mol. Endocrinol. 28:2002;69-78
Umeki S., Soejima R. Hydrocortisone inhibits the respiratory burst oxidase from human neutrophils in whole-cell and cell-free systems. Biochim. Biophys. Acta. 1052:1990;211-215
Condino-Neto A., Whitney C., Newburger P.E. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components 1. J. Immunol. 161:1998;4960-4967
Marumo T., Schini-Kerth V.B., Brandes R.P., Busse R. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension. 32:1998;1083-1088
Bekesi G., Kakucs R., Varbiro S., Racz K., Sprintz D., Feher J., Szekacs B. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids. 65:2000;889-894
Dandona P., Aljada A., Ghanim H., Mohanty P., Hamouda W., Al-Haddad W. Acute suppressive effect of hydrocortisone on p47 subunit of nicotinamide adenine dinucleotide phosphate oxidase. Metabolism. 50:2001;548-552
Iuchi T., Akaike M., Mitsui T., Ohshima Y., Shintani Y., Azuma H., Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ. Res. 92:2003;81-87
Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286
Adcock I.M., Brown C.R., Gelder C.M., Shirasaki H., Peters M.J., Barnes P.J. The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am. J. Physiol. Cell Physiol. 268:1995;331-338
Wang Y., Zhang J.J., Dai W., Lei K.Y., Pike J.W. Dexamethasone potently enhances phorbol ester-induced IL-1beta gene expression and nuclear factor NF-kappaB activation. J. Immunol. 159:1997;534-537
Franchimont D., Martens H., Hagelstein M.T., Dewe L.E., Chrousos W., Belaiche G.P.J., Geenen V. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84:1999;2834-2839
Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96:1999;1059-1064
Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., O'Shea J.J., Phrousos C.G., Bornstein S.R. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16:2002;61-71
Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21:2000;55-89